Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03424603
Title Study of STRO-001, an Anti-CD74 Antibody Drug Conjugate, in Patients With Advanced B-Cell Malignancies
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Sutro Biopharma, Inc.
Indications

diffuse large B-cell lymphoma

follicular lymphoma

non-Hodgkin lymphoma

mantle cell lymphoma

multiple myeloma

B-cell lymphoma

Therapies

STRO-001

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.